title: Giant orf with prolonged recovery in a patient with psoriatic arthritis treated with etanercept.
authors.forename: Ole Martin
authors.initials: OM
authors.lastname: Rørdam
authors.forename: Øystein
authors.initials: Ø
authors.lastname: Grimstad
authors.forename: Olav
authors.initials: O
authors.lastname: Spigset
authors.forename: Kristin
authors.initials: K
authors.lastname: Ryggen
mesh_terms: D015535:Arthritis, Psoriatic / Q000188:drug therapy* / Q000276:immunology; D001706:Biopsy; D004474:Ecthyma, Contagious / Q000209:etiology* / Q000276:immunology / Q000473:pathology / Q000628:therapy / Q000821:virology; D000068800:Etanercept; D006801:Humans; D016867:Immunocompromised Host; D007074:Immunoglobulin G / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept